Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

258 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma

NCT00780663

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +7 more
Locations
  • Birmingham Hematology and Oncology Birmingham, Alabama, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Front Range Cancer Specialists Fort Collins, Colorado, United States
  • Ocala, Florida, United States
View all 13 locations
View Trial Details
Completed

Treatment With SU11248 in Patients With Neuroendocrine Tumors

NCT00056693

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Los Angeles, California, United States
  • Pfizer Investigational Site Los Angeles, California, United States
View Trial Details
Active, Not Recruiting

Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery

NCT06204159

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations
  • Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
  • University of Pennsylvania, Department of Radiology, Interventional Radiology Division Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

NCT02568267

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +91 more
Locations
  • Dignity Health St Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Cancer Center Duarte, California, United States
  • City of Hope Duarte - Comprehensive Cancer Center, Investigational Drug Services Duarte, California, United States
View all 130 locations
View Trial Details
Active, Not Recruiting

Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer

NCT04848337

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations
  • City of Hope Duarte, California, United States
  • Winship Cancer Instituted of Emory University Atlanta, Georgia, United States
  • University of Michigan Health System Ann Arbor, Michigan, United States
  • Oregon health Portland, Oregon, United States
View Trial Details

Related conditions